Results of shareholder votes disclosed under 8-K Item 5.07.
REGENXBIO Inc. shareholders approved Election of three Class II directors at the 2026-05-29 meeting.
“Proposal 1 : By the following vote, the following three persons were elected to serve as Class II directors until the Company’s 2029 annual meeting of stockholders: Nominee Votes For Votes Withheld Broker Non-Votes Jean Bennett, M.D., Ph.D. 24,025,836 11,238,926 7,554,121 A.N. “Jerry” Karabelas, Ph.D. 27,124,923 8,139,839 7,554,121 Daniel Tassé 32,039,753 3,225,009 7,554,121”
Keenova Therapeutics plc shareholders approved Approve an amendment to the Company's articles of association (Special Resolution) at the 2026-06-02 meeting.
“FOR AGAINST ABSTAIN BROKER NON-VOTES 25,476,547 6,345 0 310,829”
Keenova Therapeutics plc shareholders approved Approve the reduction of Company capital (Special Resolution) at the 2026-06-02 meeting.
“FOR AGAINST ABSTAIN BROKER NON-VOTES 25,256,218 35,379 191,295 310,829”
Keenova Therapeutics plc shareholders approved Advisory non-binding vote to approve the frequency of future advisory non-binding votes to approve the Company's executive compensation at the 2026-06-02 meeting.
“1 YEAR 2 YEARS 3 YEARS ABSTAIN BROKER NON-VOTES 25,117,919 172,952 726 191,295 310,829”
Keenova Therapeutics plc shareholders approved Advisory non-binding vote to approve the Company's executive compensation at the 2026-06-02 meeting.
“FOR AGAINST ABSTAIN BROKER NON-VOTES 24,965,301 326,296 191,295 310,829”
Keenova Therapeutics plc shareholders approved Advisory non-binding vote to approve the re-appointment of PricewaterhouseCoopers LLP as independent auditors and to authorize the Audit Committee to set the auditors’ remuneration at the 2026-06-02 meeting.
“FOR AGAINST ABSTAIN BROKER NON-VOTES 25,602,426 0 191,295 0”
Keenova Therapeutics plc shareholders approved Election of directors to hold office until the 2027 Annual General Meeting at the 2026-06-02 meeting.
“FOR AGAINST ABSTAIN BROKER NON-VOTES Paul M. Bisaro 25,282,713 8,884 191,295 310,829”
Viridian Therapeutics, Inc.\DE shareholders approved Approval, on an advisory basis, of the frequency of holding an advisory vote on the compensation of the Company’s named executive officers at the 2026-06-02 meeting.
“4. Approval, on an advisory basis, of the frequency of holding an advisory vote on the compensation of the Company’s named executive officers: 1 Year 2 Years 3 Years Abstain 86,084,347 29,762 517,682 207,355”
Viridian Therapeutics, Inc.\DE shareholders approved Approval, on an advisory basis, of the compensation of the Company’s named executive officers at the 2026-06-02 meeting.
“3. Approval, on an advisory basis, of the compensation of the Company’s named executive officers: For Against Abstentions Broker Non-Votes 83,512,086 3,113,724 213,336 6,733,104”
Viridian Therapeutics, Inc.\DE shareholders approved Ratification of the selection of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-02 meeting.
“2. Ratification of the selection of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026: For Against Abstentions Broker Non-Votes 92,866,008 512,582 193,660 —”
Viridian Therapeutics, Inc.\DE shareholders approved Election of two Class II director nominees to serve until the 2029 Annual Meeting of Stockholders at the 2026-06-02 meeting.
“1. Election of the two Class II director nominees to serve until the 2029 Annual Meeting of Stockholders: For Withheld Broker Non-Votes Tomas Kiselak 72,363,500 14,475,646 6,733,104 Jennifer K. Moses 86,378,842 460,304 6,733,104”
ODYSSEY MARINE EXPLORATION INC shareholders approved Non-binding advisory approval of named executive officer compensation at the 2026-06-01 meeting.
“For Against Abstain 21,172,628 1,024,128 445,450”
ODYSSEY MARINE EXPLORATION INC shareholders approved Approve reverse stock split at ratio from 1-for-20 to 1-for-25 at the 2026-06-01 meeting.
“For Against Abstain 31,683,294 3,685,661 464,990”
ODYSSEY MARINE EXPLORATION INC shareholders approved Amend 2019 Stock Incentive Plan to increase authorized shares by 2,000,000 at the 2026-06-01 meeting.
“For Against Abstain 20,934,966 1,558,840 148,400”
ODYSSEY MARINE EXPLORATION INC shareholders approved Amend articles to increase authorized common stock from 75,000,000 to 82,000,000 at the 2026-06-01 meeting.
“For Against Abstain 31,871,707 3,514,241 447,997”
ODYSSEY MARINE EXPLORATION INC shareholders approved Ratification of Grant Thornton LLP as independent registered public accounting firm at the 2026-06-01 meeting.
“For Against Abstain 35,169,107 281,343 383,495”
ODYSSEY MARINE EXPLORATION INC shareholders approved Election of five directors at the 2026-06-01 meeting.
“Mark D. Gordon 22,081,067 561,139 Mark B. Justh 21,787,427 854,779 Larissa T. Pommeraud 22,011,589 630,617 Jon D. Sawyer 21,979,092 663,114 Todd E. Siegel 21,972,228 669,978”
UPBOUND GROUP, INC. shareholders approved Approval of 2026 Long-Term Incentive Plan at the 2026-01-01 meeting.
“Proposal Five: The 2026 LTIP was approved as follows: Votes For Votes Against Abstentions Broker Non-Votes 40,285,981 1,785,824 229,931 9,344,512”
UPBOUND GROUP, INC. shareholders approved Advisory vote on frequency of future say-on-pay votes at the 2026-01-01 meeting.
“Proposal Four: The frequency of future advisory votes on executive compensation voted for by stockholders, on an advisory basis, was every one year as follows: 1 Year 2 Years 3 Years Abstentions Broker Non-Votes 40,078,425 21,276 2,093,408 108,627 9,344,512”
UPBOUND GROUP, INC. shareholders approved Advisory vote on named executive officer compensation at the 2026-01-01 meeting.
“Proposal Three: The compensation of the named executive officers of the Company for the year ended December 31, 2025 was approved, on an advisory basis, as follows: Votes For Votes Against Abstentions Broker Non-Votes 41,399,464 648,319 253,953 9,344,512”
UPBOUND GROUP, INC. shareholders approved Ratification of Deloitte & Touche LLP as independent auditor at the 2026-01-01 meeting.
“Proposal Two: The selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 was ratified with voting on the proposal as follows: Votes For Votes Against Abstentions Broker Non-Votes 51,048,562 396,908 200,778 0”
UPBOUND GROUP, INC. shareholders approved Election of directors at the 2026-01-01 meeting.
“Proposal One: Having received more than a majority of votes cast at the meeting, each of the individuals named below was re-elected as a director: Nominee Votes For Votes Against Abstentions Broker Non-Votes Jeffrey Brown 41,070,290 1,129,349 102,097 9,344,512 Charu Jain 41,811,163 378,373 112,200 9,344,512 Fahmi Karam 41,800,572 394,653 106,511 9,344,512 Molly Langenstein 41,702,939 492,933 105,864 9,344,512 Harold Lewis 41,741,349 453,178 107,209 9,344,512 Glenn Marino 41,559,473 635,027 107,236 9,344,512 Carol McFate 41,030,123 1,164,818 106,795 9,344,512”
PubMatic, Inc. shareholders approved Advisory Vote on the Compensation of the Named Executive Officers at the 2026-05-29 meeting.
“The Company’s stockholders approved, on an advisory basis, the compensation paid by the Company to its named executive officers, by the following votes:”
PubMatic, Inc. shareholders approved Ratification of Appointment of Independent Registered Accounting Firm at the 2026-05-29 meeting.
“The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered accounting firm for the year ending December 31, 2026 by the following votes:”
PubMatic, Inc. shareholders approved Election of eight directors at the 2026-05-29 meeting.
“The Company’s stockholders approved the election of eight directors, each to serve for a one-year term expiring at the 2026 Annual Meeting of Stockholders and until such director’s successor is elected and qualified, by the following votes:”
Turtle Beach Corp shareholders approved Non-binding, advisory vote on the compensation of NEOs at the 2026-06-02 meeting.
“Item 3. Non-binding, advisory vote on the compensation of NEOs. For Against Abstain Broker Non-Vote 8,469,269 172,584 14,466 3,939,697”
Turtle Beach Corp shareholders approved Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 at the 2026-06-02 meeting.
“Item 2. Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. For Against Abstain 12,380,259 207,376 8,381”
Turtle Beach Corp shareholders approved Election of six members to the Board of Directors at the 2026-06-02 meeting.
“Item 1. Election of six members to the Board of Directors. Nominee For Against Abstain Broker Non-Vote William Wyatt 7,921,944 731,238 3,137 3,939,697 Libby B. Bush 7,756,653 894,809 4,857 3,939,697 Lee Haspel 8,348,699 284,043 23,577 3,939,697 Cris Keirn 8,182,398 470,470 3,451 3,939,697 Daniela Kelley 8,348,980 283,663 23,676 3,939,697 Julia W. Sze 8,042,471 610,183 3,665 3,939,697”
Orgenesis Inc. shareholders approved Ratification of appointment of Kesselman & Kesselman C.P.A.s (member firm of PricewaterhouseCoopers) as independent registered public accounting firm for fiscal year ending December 31, 2025 at the 2026-05-27 meeting.
“Proposal 3. Ratification of Auditors The approval of the ratification of the appointment of Kesselman & Kesselman C.P.A.s, a member firm of PricewaterhouseCoopers International Limited, as our independent registered public accounting firm for the fiscal year ending December 31, 2025: For Against Abstain 6,400,038 14,552 1,141”
Orgenesis Inc. shareholders approved Share Issuance Proposal - approval of Convertible Loan Agreement and potential issuance of shares at the 2026-05-27 meeting.
“Proposal 2. Share Issuance Proposal The approval of the Convertible Loan Agreement, dated September 10, 2025, by and among Theracell Laboratories IKE, Orgenesis Inc., and Alpha Prosperity Fund SPC, acting on behalf of and for the account of Segregated Portfolio P, and the potential issuance of shares of common stock of Orgenesis Inc. pursuant thereto: For Against Abstain 5,172,526 27,026 1,201,280”
Orgenesis Inc. shareholders approved Amendment to Articles of Incorporation to increase authorized shares of common stock from 14,583,333 to 150,000,000 at the 2026-05-27 meeting.
“Proposal 1. Amendment to Articles of Incorporation to Increase Authorized Shares of Common Stock The approval of a proposal to approve an amendment to the Company’s Articles of Incorporation, as amended, to increase the number of authorized shares of common stock from 14,583,333 to 150,000,000: For Against Abstain 5,153,345 61,005 1,201,381”
ACI WORLDWIDE, INC. shareholders approved Advisory approval of named executive compensation as described in the 2026 Proxy Statement at the 2026-06-02 meeting.
“The stockholders approved, on an advisory basis, the named executive compensation as described in the 2026 Proxy Statement.”
ACI WORLDWIDE, INC. shareholders approved Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-02 meeting.
“The stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”
ACI WORLDWIDE, INC. shareholders approved Election of nine nominees to the Board of Directors at the 2026-06-02 meeting.
“The stockholders elected each of the following nine nominees to the Board of Directors to hold office until the 2027 Annual Meeting of Stockholders.”
Shattuck Labs, Inc. shareholders approved Approval of Amendment and Restatement of the 2020 Equity Incentive Plan.
“Proposal 5. Approval of Amendment and Restatement of the 2020 Equity Incentive Plan 43,498,166 10,709,563 17 10,607,421”
Shattuck Labs, Inc. shareholders approved Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation.
“1 Year 2 Years 3 Years Abstentions Broker Non-Votes Proposal 4. Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation 53,948,458 21,627 237,643 18 10,607,421”
Shattuck Labs, Inc. shareholders approved Advisory Vote on Executive Compensation.
“Proposal 3. Advisory Vote on Executive Compensation 49,849,887 4,356,199 1,660 10,607,421”
Shattuck Labs, Inc. shareholders approved Ratification of KPMG LLP as Independent Auditor.
“Proposal 2. Ratification of KPMG LLP as Independent Auditor 64,802,807 7,317 5,043 0”
Shattuck Labs, Inc. shareholders approved Election of Class III Director Nominees.
“Proposal 1. Election of Class III Director Nominees • Taylor Schreiber, M.D., Ph.D. 51,347,234 2,860,512 10,607,421 • Helen M. Boudreau 50,110,095 4,097,651 10,607,421 • Clay Siegall, Ph.D. 50,388,129 3,819,617 10,607,421”
VISTA CREDIT STRATEGIC LENDING CORP. shareholders approved Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-05-28 meeting.
“Proposal 2. To ratify the selection of Deloitte & Touche LLP to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. Votes For Votes Against Abstain 28,081,520 0 112,493”
VISTA CREDIT STRATEGIC LENDING CORP. shareholders approved Election of one Class III director to serve until 2029 annual meeting at the 2026-05-28 meeting.
“Proposal 1. To elect one Class III director of the Company who will serve until the 2029 annual meeting of stockholders of the Company or until his successor is duly elected and qualified. Name Votes For Votes Against Abstain Stephen Riddick 28,073,001 61 120,951”
VARONIS SYSTEMS INC shareholders approved To approve additional shares for issuance under the Amended and Restated Varonis Systems, Inc. 2023 Omnibus Equity Incentive Plan at the 2026-06-01 meeting.
“PROPOSAL NO. 4 To approve additional shares for issuance under the Amended and Restated Varonis Systems, Inc. 2023 Omnibus Equity Incentive Plan For Against Abstain Broker Non-Votes 81,381,236 9,715,526 70,090 9,029,268”
VARONIS SYSTEMS INC shareholders approved To ratify the appointment by the Audit Committee of the Board of Directors of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global Limited, as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026 at the 2026-06-01 meeting.
“PROPOSAL NO. 3 To ratify the appointment by the Audit Committee of the Board of Directors of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global Limited, as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026 For Against Abstain Broker Non-Votes 96,222,394 3,931,624 42,102 -”
VARONIS SYSTEMS INC shareholders approved Advisory vote to approve the Company's executive compensation, as disclosed in the Proxy Statement at the 2026-06-01 meeting.
“PROPOSAL NO. 2 Advisory vote to approve the Company's executive compensation, as disclosed in the Proxy Statement For Against Abstain Broker Non-Votes 83,058,191 7,994,373 114,288 9,029,268”
VARONIS SYSTEMS INC shareholders approved To elect the four nominees for director named below to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders at the 2026-06-01 meeting.
“PROPOSAL NO. 1 To elect the four nominees for director named below to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders For Withheld Broker Non-Votes Yakov Faitelson 84,726,187 6,440,665 9,029,268 Thomas Mendoza 86,087,842 5,079,010 9,029,268 Avrohom J. Kess 83,030,783 8,136,069 9,029,268 Ohad Korkus 85,200,709 5,966,143 9,029,268”
Village Farms International, Inc. shareholders approved Re-appointing KPMG LLP as the independent registered public accounting firm to serve as the Company’s independent auditor for the fiscal year ending December 31, 2026, and authorizing the directors to fix their remuneration at the 2026-06-02 meeting.
“Proposal No. 3: Re-appointing KPMG LLP as the independent registered public accounting firm to serve as the Company's independent auditor for the fiscal year ending December 31, 2026, and authorizing the directors to fix their remuneration: Votes For % For Votes Withheld % Withheld Broker Non-Votes 56,057,521 98.23% 1,011,953 1.77% 2”
Village Farms International, Inc. shareholders approved Approval of the compensation of the Company’s named executive officers on an advisory, non-binding basis at the 2026-06-02 meeting.
“Proposal No. 2: The approval of the compensation of the Company’s named executive officers on an advisory, non-binding basis, received the following votes: Votes For % of Voted Votes Against % of Voted Abstain % of Voted Broker Non-Votes 22,207,526 95.22% 1,035,201 4.44% 79,498 0.34% 33,747,251”
Village Farms International, Inc. shareholders approved Election of the Board of Directors to serve until the 2027 Annual Meeting of Shareholders or until their successors are elected or appointed at the 2026-06-02 meeting.
“Proposal No. 1: The election of the Board of Directors to serve until the 2027 Annual Meeting of Shareholders or until their successors are elected or appointed, received the following votes: Nominee Votes For % For Votes Withheld % Withheld Broker Non-Votes John R. McLernon 20,796,037 89.17% 2,526,189 10.83% 33,747,250 John P. Henry 20,793,950 89.16% 2,528,276 10.84% 33,747,250 David Holewinski 20,924,980 89.72% 2,397,247 10.28% 33,747,249 Kathleen M. Mahoney 22,872,105 98.07% 450,121 1.93% 33,747,250 Christopher C. Woodward 20,819,241 89.27% 2,502,985 10.73% 33,747,250 Carolyn Hauger 22,969,457 98.49% 352,766 1.51% 33,747,253 Michael A. DeGiglio 23,080,981 98.97% 241,245 1.03% 33,747,250”
Dave Inc./DE shareholders approved Ratification of Deloitte & Touche LLP at the 2026-06-02 meeting.
“Proposal 4: Ratification of Deloitte & Touche LLP The Company’s stockholders ratified the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The votes regarding Proposal 4 were as follows: Votes For Votes Against Votes Abstained Broker Non-Votes 22,358,229 40,988 36,999 —”
Dave Inc./DE shareholders approved Advisory Vote on the Frequency of Future Advisory Votes on Dave's Executive Compensation at the 2026-06-02 meeting.
“Proposal 3: Advisory Vote on the Frequency of Future Advisory Votes on Dave’s Executive Compensation The Company’s stockholders approved, on an advisory basis, the option of every 1 year for the frequency of future advisory votes on Dave’s executive compensation. The votes regarding Proposal 3 were as follows: 1 Year 2 Years 3 Years Votes Abstained Broker Non-Votes 19,948,465 175,469 142,503 19,718 2,150,061”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.